GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Grifols SA (NAS:GRFS) » Definitions » Other Stockholders Equity

GRFS (Grifols) Other Stockholders Equity : $-0 Mil (As of Sep. 2024)


View and export this data going back to 2011. Start your Free Trial

What is Grifols Other Stockholders Equity?

Grifols's Other Stockholders Equity for the quarter that ended in Sep. 2024 was $-0 Mil.

Grifols's quarterly Other Stockholders Equity declined from Dec. 2023 ($0 Mil) to Jun. 2024 ($-0 Mil) but then stayed the same from Jun. 2024 ($-0 Mil) to Sep. 2024 ($-0 Mil).

Grifols's annual Other Stockholders Equity increased from Dec. 2021 ($-0 Mil) to Dec. 2022 ($-0 Mil) and increased from Dec. 2022 ($-0 Mil) to Dec. 2023 ($0 Mil).

Grifols Other Stockholders Equity Historical Data

The historical data trend for Grifols's Other Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Grifols Other Stockholders Equity Chart

Grifols Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Other Stockholders Equity
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Grifols Quarterly Data
Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Dec21 Jun22 Sep22 Dec22 Jun23 Sep23 Dec23 Jun24 Sep24
Other Stockholders Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Grifols Other Stockholders Equity Calculation

Other Stockholders Equity is instruments issued by the company that cannot be identified by other specific items in the Equity section. GuruFocus lists following items in "Total Stockholders Equity" section:
Common Stock
Preferred Stock
Retained Earnings
Accumulated other comprehensive income (loss)
Additional Paid-In Capital
Treasury Stock
Other Stockholders Equity

Grifols Other Stockholders Equity Related Terms

Thank you for viewing the detailed overview of Grifols's Other Stockholders Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

Grifols Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Grifols SA (NAS:GRFS) » Definitions » Other Stockholders Equity
Comparable Companies
XMAD:PUIG XMAD:BKT XMAD:ALQ XMAD:GEST XMAD:UNI XMAD:NEA XMAD:FCC XMAD:CEV XMAD:SAB XMAD:MAP LLY OCSE:NOVO B JNJ ABBV MRK XSWX:ROG LSE:AZN XSWX:NOVN AMGN PFE
Traded in Other Exchanges
GIKLY:USA GIFOF:USA GIFLF:USA GRFe:UK GRFPe:UK 0RDV:UK 0RDU:UK GRF.P:Spain GRF:Spain G0F0:Germany GRF:Austria
Address
Avinguda de la Generalitat, 152, Parc de Negocis Can Sant Joan, Sant Cugat del Valles, Barcelona, ESP, 08174
Website
https://www.grifols.com
As a vertically integrated plasma derivative producer, Spain-based Grifols collects plasma and then manufactures and sells plasma-derived products globally. By acquiring Talecris in 2011, Grifols dramatically expanded its plasma-derived product portfolio, and following the firm's Biotest acquisition in April 2022, the biopharma business contributed 84% of sales in 2023. Grifols also has smaller segments including diagnostics (10% of sales) and biosupplies.